M&A

Teva makes unsolicited $40B bid for rival Mylan in effort to spawn generics titan
BioPharma Dive
Tue, 04/21/15 - 12:16 pm
Teva Pharmaceutical
Mylan
M&A
Surging Actelion is on the hunt for buyouts amid 'M&A frenzy'
Fierce Biotech
Tue, 04/21/15 - 09:34 am
Actelion
M&A
Teva declines to comment on report it to make offer for Mylan
Yahoo/Reuters
Tue, 04/21/15 - 09:28 am
Teva Pharmaceutical
Mylan
M&A
Gilead Should Buy Vertex Pharma for $45B Now, Analyst Says
TheStreet.com
Tue, 04/21/15 - 09:26 am
Gilead Sciences
Vertex Pharma
M&A
Teva Plans Public Mylan Approach in Largest Drug Deal
Yahoo/Bloomberg
Tue, 04/21/15 - 09:23 am
Teva Pharmaceutical
Mylan
M&A
Gilead Sciences: Serious Cash Means An Acquisition Could Be Coming Soon
Seeking Alpha
Mon, 04/20/15 - 05:18 pm
M&A
Gilead Sciences
St. Jude to buy maker of chronic pain device
Bizjournals.com
Mon, 04/20/15 - 05:12 pm
M&A
devices
St. Jude Medical
chronic pain
Spinal Modulation
Daiichi Sankyo cashing out after merging Ranbaxy with Sun
Fierce Pharma
Mon, 04/20/15 - 05:10 pm
Daiichi Sankyo
Ranbaxy
M&A
Sun Pharma
[video]Inside a Possible Teva, Mylan Merger
Bloomberg
Mon, 04/20/15 - 12:12 pm
Teva Pharmaceutical
Mylan
M&A
Is Teva considering a $34B Mylan buyout to offset Copaxone losses?
BioPharma Dive
Mon, 04/20/15 - 11:59 am
Teva Pharmaceutical
Mylan
M&A
Copaxone
Which deal gets done: Teva's rumored Mylan bid or Mylan's Perrigo offer?
Fierce Pharma
Mon, 04/20/15 - 11:17 am
Teva Pharmaceutical
Mylan
Perrigo
M&A
Teva Can Preserve $5-a-Share Earnings Goal With Mylan: Real M&A
Bloomberg
Sat, 04/18/15 - 12:12 pm
Teva Pharmaceutical
Mylan
M&A
Mylan skeptical of rumored Teva bid; hasn't received offer
Yahoo/AP
Sat, 04/18/15 - 11:58 am
Mylan
Teva Pharmaceutical
M&A
Big pharma M&A may keep booming, CEOs say
CNBC
Fri, 04/17/15 - 08:46 am
Big Pharma
M&A
Pharma CEOs
Ian Read
Pfizer
Kenneth Frazier
Merck
How Lucrative Is Mylan’s Acquisition of Perrigo?
Yahoo/Market Realist
Thu, 04/16/15 - 01:02 pm
Mylan
Perrigo
M&A
Five companies that may be looking to buy Ariad Pharmaceuticals
Bizjournals.com
Wed, 04/15/15 - 08:44 am
Ariad Pharmaceuticals
M&A
Roche
Celgene
AbbVie
Gilead Sciences
Pfizer
Zimmer extends deadline for $13B Biomet deal
Mass Device
Tue, 04/14/15 - 09:48 am
Zimmer
Biomet
M&A
devices
Water under the bridge: Allergan, Ackman drop hostile takeover lawsuits
BioPharma Dive
Tue, 04/14/15 - 09:47 am
Allergan
Bill Ackman
M&A
Valeant Pharmaceuticals
Mylan's $29B Perrigo bid seen as defensive play against M&A threat
BioPharma Dive
Tue, 04/14/15 - 09:46 am
Mylan
Perrigo
M&A
Will Mylan's $29B bid spur other Perrigo suitors to enter the fray?
Fierce Pharma
Fri, 04/10/15 - 04:05 pm
Mylan
Perrigo
M&A
JNJ
Pfizer
AmerisourceBergen

Pages